ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 154 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $588,000 | -2.0% | 48,800 | +317.1% | 0.01% | -14.3% |
| Q2 2020 | $600,000 | +192.7% | 11,700 | +80.0% | 0.01% | +133.3% |
| Q1 2020 | $205,000 | -58.6% | 6,500 | -21.7% | 0.00% | -40.0% |
| Q4 2019 | $495,000 | +7.1% | 8,300 | -34.1% | 0.01% | 0.0% |
| Q3 2019 | $462,000 | +111.0% | 12,600 | +168.1% | 0.01% | +66.7% |
| Q2 2019 | $219,000 | -36.9% | 4,700 | -2.1% | 0.00% | -25.0% |
| Q1 2018 | $347,000 | +22.6% | 4,800 | -78.8% | 0.00% | 0.0% |
| Q4 2016 | $283,000 | +16.9% | 22,600 | +29.1% | 0.00% | +33.3% |
| Q3 2016 | $242,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |